VANCOUVER, Sept. 12, 2016 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (CSE: ACB)(OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM), one of Canada's leading Licensed Producers of medical cannabis, is pleased to announce an industry first, with the launch of what is believed
Mobile App Photo and Video Available
Aurora mobile app photo: https://auroramj.com/app/AuroraCannabisAppImage.jpg Aurora mobile app video: https://auroramj.com/app/AuroraCannabisAppVideo.mp4
"Our objective is always to provide the best customer care in the industry, consistent with the Aurora Standard, and our new mobile app is further proof of that commitment," said Neil Belot, Chief Brand Officer. "This is a great value add for our loyal clients, and delivers an enhanced overall experience. It's easy to use, fast and convenient. Customers often spend more time visiting our website from their mobile phone or tablet than they do from their desktop. The app puts ordering right at their fingertips, and lets us communicate and engage with them even more effectively."
Latest Innovation from Fast-Growing Cannabis Company
Aurora, which began commercial operations in January, 2016, has set the fastest pace of growth in Canada's burgeoning medical cannabis sector. The Company announced on September 6, 2016 that it had surpassed 7,700 active registered patients, less than eight months after first sale of product. The new mobile app is the latest innovation from Aurora, which on May 24, 2016 became the first Licensed Producer to offer same-day delivery at no additional cost, a service provided to its customers in the Calgary and surrounding communities.
On August 23, 2016, Aurora announced the completion of the design, engineering, and tender process for the construction of the first phase of a 600,000 square foot expansion. When completed, the high-technology, fully automated greenhouse is expected to be the most advanced cannabis production facility in the world.
"I am delighted with our ability to lead the way in the cannabis sector, not only through providing patients with medical cannabis of the highest quality and consistency, but also by bringing valuable, industry-leading innovations to our customers," said Terry Booth, CEO.
Aurora's wholly-owned subsidiary, Aurora Cannabis Enterprises Inc., is a licensed producer of medical marijuana pursuant to Health Canada's Access to Cannabis for Medical Purposes Regulations (ACMPR) and operates a 55,200 square foot, expandable, state-of-the-art production facility in Mountain View County, Alberta, Canada. Aurora trades on the Canadian Securities Exchange under the symbol "ACB".
On behalf of the Board of Directors, AURORA CANNABIS INC.
Terry Booth, CEO
This news release contains statements about the Company's expectations regarding production capacity, production yields and other aspects of its anticipated future operations that are forward-looking in nature and, as a result, are subject to certain risks and uncertainties. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, undue reliance should not be placed on them as actual results may differ materially from the forward-looking statements. Such forward-looking statements are estimates reflecting the Company's best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. Such factors include but are not limited to the Company's ability to obtain the necessary financing and the general impact of financial market conditions, the yield from marijuana growing operations, product demand, changes in prices of required commodities, competition, government regulations and other risks set out in the Company's management's discussion and analysis filed on SEDAR. The forward-looking statements contained in this news release are made as of the date hereof, and the Company undertakes no obligation to update publicly or revise any forward-looking statements or information, except as required by law.
The CSE or other regulatory authority has not reviewed, approved or disapproved the contents of this press release. We seek Safe Harbour.
SOURCE Aurora Cannabis Inc.
Subscribe to our Free Newsletters!
Nocturnal polyuria refers to increased urine output during night, without an associated increase in ...
Nootropics are drugs or substances which improve cognition that are being increasingly used ...
Pterygium or Surfer's eye is described as a proliferative disorder of the ocular surface possibly ...View All